Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16

1.

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA, et al.

N Engl J Med. 1993 Jun 17;328(24):1740-6.

3.

Efficacy and safety of aerosolized tobramycin in cystic fibrosis.

Pai VB, Nahata MC.

Pediatr Pulmonol. 2001 Oct;32(4):314-27. Review.

PMID:
11568993
4.

Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.

Geller DE, Pitlick WH, Nardella PA, Tracewell WG, Ramsey BW.

Chest. 2002 Jul;122(1):219-26. Review.

PMID:
12114362
5.

Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: a review.

Ratjen F, Brockhaus F, Angyalosi G.

J Cyst Fibros. 2009 Dec;8(6):361-9. doi: 10.1016/j.jcf.2009.08.004. Epub 2009 Sep 10. Review.

6.
7.

Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis.

Fiel SB.

Chest. 1995 Feb;107(2 Suppl):61S-64S. Review.

PMID:
7842815
8.

Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature.

Hagerman JK, Knechtel SA, Klepser ME.

Expert Opin Pharmacother. 2007 Mar;8(4):467-75. Review.

PMID:
17309341
9.

[Use of inhaled tobramycin in patients with cystic fibrosis].

Chermenskiĭ AG, Gembitskaia TE.

Ter Arkh. 2010;82(8):76-8. Review. Russian.

PMID:
20873251
10.

TOBI: reducing the impact of pseudomonal infection.

Govan J.

Hosp Med. 2002 Jul;63(7):421-5. Review.

PMID:
12187603
11.

Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Parkins MD, Elborn JS.

Expert Rev Respir Med. 2011 Oct;5(5):609-22. doi: 10.1586/ers.11.56. Review.

PMID:
21955231
12.

[Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection].

Mordasini C, Aebischer CC, Schoch OD.

Schweiz Med Wochenschr. 1997 May 24;127(21):905-10. Review. German.

PMID:
9289818
13.

Inhaled aztreonam lysine for cystic fibrosis pulmonary disease-related outcomes.

Pesaturo KA, Horton ER, Belliveau P.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1076-85. doi: 10.1345/aph.1Q653. Epub 2012 Jul 3. Review.

PMID:
22764322
14.

Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.

Rubin BK.

J Aerosol Med Pulm Drug Deliv. 2008 Mar;21(1):71-6. doi: 10.1089/jamp.2007.0652. Review.

PMID:
18518833
15.

Inhalation of antibiotics in cystic fibrosis.

Touw DJ, Brimicombe RW, Hodson ME, Heijerman HG, Bakker W.

Eur Respir J. 1995 Sep;8(9):1594-604. Review.

16.

Formulation of aerosolized therapeutics.

Kuhn RJ.

Chest. 2001 Sep;120(3 Suppl):94S-98S. Review.

PMID:
11555562
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk